As a predictor of sudden cardiac death it has been shown to be highly accurate, with a sensitivity approaching 100% and a specificity of ~86%.

No stress-testing or any active participation from the patient is required.

A large physician shareholder base represents the early adoptees of this Company.

The PD2i™ Nonlinear Algorithm has been cleared by the FDA for marketing as a measure of Heart Rate Variability and already has a billing code — so providers can be paid.

Vicor’s PD2i™ Nonlinear Algorithm

The PD2i Analyzer™ can capture and display Heart Rate Variabilityin patients at rest and during paced respiration and controlled exercise.

    * Able to identify trauma victims in need of an immediate lifesaving intervention
    * Able to be used along with other clinical data to identify patients at risk of sudden cardiac death
    * Able to be used along with other clinical data to identify patients who have autonomic dysfunction
    * Able to improve trauma triage in real world situations and on the battlefield where time is of the essence and the collection of ‘clean’ data is never guaranteed
    * Able to provide consistently accurate results which requires just one to two minutes of EKG data in a trauma setting
    * Not derailed in delivering actionable results by noisy raw EKG data
    * Functional in trauma environments and battlefield situations

Vicor’s Three Products Employing the PD2i™ Nonlinear Algorithm.

    * PD2i Analyzer(TM) has FDA 510(k) marketing clearance. It measures Heart Rate Variability. Physicians performing diagnostic tests with the PD2i Analyzer™ are able to receive reimbursement under existing CPT codes.
    * PD2i VS(TM) (Vital Sign) stratifies risk in combat and civilian trauma victims and is in clinical trials under a collaborative effort with the U.S. Army Institute for Surgical Research. (http://www.usaisr.amedd.army.mil/)
    * PD2i CA(TM) (Cardiac Analyzer) identifies patients at risk of sudden cardiac death and is in multiple clinical trials.

The PD2i Analyzer™ has been cleared by the FDA for marketing as a measure of Heart Rate Variability. It quantifies the relationship between the patient’s heart and brain by measuring the heart rate variation over time. The PD2i® test is painless and much like a value-added electrocardiogram. Adhesive sensor pads are placed on the skin and for the next twenty minutes the Analyzer records heartbeat information. Exercise is not necessary during the test.

The PD2i Analyzer™ twenty-minute test is composed of recording a sequence of one thousand heartbeats. The PD2i™ nonlinear algorithm is subsequently applied to that recording in order to find subtle patterns in the resulting data, yielding the final result which is expressed as a minimum PD2i™ value.

Vicor Technologies, Inc.
2300 NW Corporate Blvd.
Suite 123
Boca Raton, FL 33431
877.528-PD2i (7324)

Comments

Search RSS

All rights reserved."